72 related articles for article (PubMed ID: 3209123)
1. Density distribution of red cells and prognostic significance in 50 patients with homozygous sickle-cell disease.
Pajot N; Maier-Redelsperger M; Dode C; Labie D; Girot R
Haematologia (Budap); 1988; 21(4):189-97. PubMed ID: 3209123
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
[TBL] [Abstract][Full Text] [Related]
3. Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity.
Powars DR; Meiselman HJ; Fisher TC; Hiti A; Johnson C
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):55-61. PubMed ID: 7508688
[TBL] [Abstract][Full Text] [Related]
4. Influence of plasma and red cell factors on the rheologic properties of oxygenated sickle blood during clinical steady state.
Morris CL; Gruppo RA; Shukla R; Rucknagel DL
J Lab Clin Med; 1991 Oct; 118(4):332-42. PubMed ID: 1940575
[TBL] [Abstract][Full Text] [Related]
5. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil.
Figueiredo MS; Kerbauy J; Gonçalves MS; Arruda VR; Saad ST; Sonati MF; Stoming T; Costa FF
Am J Hematol; 1996 Oct; 53(2):72-6. PubMed ID: 8892730
[TBL] [Abstract][Full Text] [Related]
6. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
[TBL] [Abstract][Full Text] [Related]
7. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
[TBL] [Abstract][Full Text] [Related]
8. Beta-globin gene cluster haplotypes in sickle cell patients from southwest Iran.
Rahimi Z; Karimi M; Haghshenass M; Merat A
Am J Hematol; 2003 Nov; 74(3):156-60. PubMed ID: 14587041
[TBL] [Abstract][Full Text] [Related]
9. Current observations on sickle cell genotype in Nigeria.
Nduka N; Owhochuku SM; Odike P
East Afr Med J; 1993 Oct; 70(10):646-9. PubMed ID: 7514527
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the alpha alpha alpha globin gene haplotype and sickle haemoglobin.
Higgs DR; Clegg JB; Weatherall DJ; Serjeant BE; Serjeant GR
Br J Haematol; 1984 Aug; 57(4):671-8. PubMed ID: 6331494
[TBL] [Abstract][Full Text] [Related]
11. Red cell distribution width parallels dense red cell disappearance during painful crises in sickle cell anemia.
Lawrence C; Fabry ME; Nagel RL
J Lab Clin Med; 1985 Jun; 105(6):706-10. PubMed ID: 3998622
[TBL] [Abstract][Full Text] [Related]
12. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.
Helley D; Eldor A; Girot R; Ducrocq R; Guillin MC; Bezeaud A
Thromb Haemost; 1996 Sep; 76(3):322-7. PubMed ID: 8883264
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound hemoglobin in the erythrocytes of sickle cell anemia.
Sears DA; Luthra MG
J Lab Clin Med; 1983 Nov; 102(5):694-8. PubMed ID: 6631167
[TBL] [Abstract][Full Text] [Related]
14. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.
Vasavda N; Badiger S; Rees D; Height S; Howard J; Thein SL
Br J Haematol; 2008 Nov; 143(4):589-92. PubMed ID: 18764867
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of pediatric patients with sickle cell anemia and stroke.
Sarnaik SA; Ballas SK
Am J Hematol; 2001 Jul; 67(3):179-82. PubMed ID: 11391715
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory features of sickle cell disease in The Netherlands.
Aluoch JR; De Geus A; Goudsmit R
Trop Geogr Med; 1988 Jan; 40(1):7-12. PubMed ID: 3381319
[TBL] [Abstract][Full Text] [Related]
18. Effect of alpha-globin genotype on the pathophysiology of sickle cell disease.
Ballas SK
Pediatr Pathol Mol Med; 2001; 20(2):107-21. PubMed ID: 12673836
[TBL] [Abstract][Full Text] [Related]
19. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Ca(2+)-containing vesicles in sickle cell disorders.
Westerman MP; Puchulu E; Schlegel RA; Salameh M; Williamson P
J Lab Clin Med; 1994 Sep; 124(3):416-20. PubMed ID: 8083584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
